Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice.
about
The New Era of Drug Therapy for Obesity: The Evidence and the ExpectationsAggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experienceGUCY2C: at the intersection of obesity and cancerThe insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous systemFixed-dose combination of phentermine-topiramate for the treatment of obesity.Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes.Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.Topiramate effects lipolysis in 3T3-L1 adipocytes.Blood-Brain Barrier Disruption and Neurovascular Unit Dysfunction in Diabetic Mice: Protection with the Mitochondrial Carbonic Anhydrase Inhibitor Topiramate.The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity.Hypothalamic Phosphodiesterase 3B Pathway Mediates Anorectic and Body Weight-Reducing Effects of Insulin in Male Mice.Psychopharmacological advances in eating disorders.Neural circuits of eating behaviour: Opportunities for therapeutic development.Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.
P2860
Q26827555-1DB29171-E486-46B1-8C25-14BFDD8C3C76Q36291168-1B90B04F-060F-49E5-BD38-3B59671E1AD2Q36741685-09114D3E-6D03-404C-8093-C1BDE510C961Q37237179-265BDD03-D505-4F8E-989B-3479B45B3D91Q38105146-5BFE5603-933D-4197-BF80-1C0471AF6B20Q38109215-200CADE7-9689-4A03-96AE-A736BCCE232DQ38812405-6BAFECF8-471F-4C9F-9637-222ED70C4FA6Q42817480-D1F2C2D3-6C37-483A-82FD-344AA57B2655Q44442577-8E7933E8-83F5-4F9D-9A92-24D1494EAFE7Q46249649-3511F911-4B82-4547-B5A2-316010EE616BQ47316523-5FE3E633-36CD-414C-8E77-12F203EEDFD6Q48103049-8582F009-D25B-49AC-9C6B-3CD6F49DBC96Q50046451-690C4019-574A-4827-9582-253DFEC6AA31Q52927184-779959A9-E00A-447F-9553-2CD1BA59BFE5
P2860
Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Topiramate treatment improves ...... n and reduces obesity in mice.
@en
Topiramate treatment improves ...... n and reduces obesity in mice.
@nl
type
label
Topiramate treatment improves ...... n and reduces obesity in mice.
@en
Topiramate treatment improves ...... n and reduces obesity in mice.
@nl
prefLabel
Topiramate treatment improves ...... n and reduces obesity in mice.
@en
Topiramate treatment improves ...... n and reduces obesity in mice.
@nl
P2093
P356
P1433
P1476
Topiramate treatment improves ...... on and reduces obesity in mice
@en
P2093
Andrea M Caricilli
Andressa C Santos
Daniella Razolli
Dioze Guadagnini
Erica Penteado
Francine C Mittestainer
Licio A Velloso
Lélia L de Abreu
Mario J A Saad
Patricia O Prada
P304
P356
10.1210/EN.2012-1272
P407
P577
2012-07-20T00:00:00Z